Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Haematology nurses' perspectives of their patients' places of care and death: A UK qualitative interview study.

McCaughan D, Roman E, Smith AG, Garry AC, Johnson MJ, Patmore RD, Howard MR, Howell DA.

Eur J Oncol Nurs. 2019 Apr;39:70-80. doi: 10.1016/j.ejon.2019.02.003. Epub 2019 Feb 7.

2.

The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.

Kane E, Painter D, Smith A, Crouch S, Oliver S, Patmore R, Roman E.

Cancer Epidemiol. 2019 Apr;59:236-243. doi: 10.1016/j.canep.2019.02.014. Epub 2019 Mar 4.

3.

Perspectives of bereaved relatives of patients with haematological malignancies concerning preferred place of care and death: A qualitative study.

McCaughan D, Roman E, Smith AG, Garry AC, Johnson MJ, Patmore RD, Howard MR, Howell DA.

Palliat Med. 2019 Jan 30:269216318824525. doi: 10.1177/0269216318824525. [Epub ahead of print]

PMID:
30696347
4.

Disease-related factors affecting timely lymphoma diagnosis: a qualitative study exploring patient experiences.

Howell DA, Hart RI, Smith AG, Macleod U, Patmore R, Roman E.

Br J Gen Pract. 2019 Feb;69(679):e134-e145. doi: 10.3399/bjgp19X701009. Epub 2019 Jan 28.

5.

Receiving treatment at a specialist centre confers an overall survival benefit for patients with mantle cell lymphoma.

McCulloch R, Smith A, Crosbie N, Patmore R, Rule S.

Br J Haematol. 2018 Nov 26. doi: 10.1111/bjh.15696. [Epub ahead of print] No abstract available.

PMID:
30474177
6.

Cell-of-origin in diffuse large B-cell lymphoma: findings from the UK's population-based Haematological Malignancy Research Network.

Painter D, Barrans S, Lacy S, Smith A, Crouch S, Westhead D, Sha C, Patmore R, Tooze R, Burton C, Roman E.

Br J Haematol. 2018 Nov 8. doi: 10.1111/bjh.15619. [Epub ahead of print] No abstract available.

PMID:
30408148
7.

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data.

Wang HI, Roman E, Crouch S, Aas E, Burton C, Patmore R, Smith A.

Value Health. 2018 Oct;21(10):1176-1185. doi: 10.1016/j.jval.2018.03.007. Epub 2018 Apr 24.

8.

Cohort Profile: The Haematological Malignancy Research Network (HMRN); a UK population-based patient cohort.

Smith A, Howell D, Crouch S, Painter D, Blase J, Wang HI, Hewison A, Bagguley T, Appleton S, Kinsey S, Burton C, Patmore R, Roman E.

Int J Epidemiol. 2018 Apr 2. doi: 10.1093/ije/dyy044. [Epub ahead of print] No abstract available.

9.

Myeloma: Patient accounts of their pathways to diagnosis.

Howell DA, Hart RI, Smith AG, Macleod U, Patmore R, Cook G, Roman E.

PLoS One. 2018 Apr 4;13(4):e0194788. doi: 10.1371/journal.pone.0194788. eCollection 2018.

10.

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN).

Smith A, Roman E, Appleton S, Howell D, Johnson R, Burton C, Patmore R.

Br J Haematol. 2018 Apr;181(2):215-228. doi: 10.1111/bjh.15170. Epub 2018 Mar 13.

11.

Palliative care specialists' perceptions concerning referral of haematology patients to their services: findings from a qualitative study.

McCaughan D, Roman E, Smith AG, Garry AC, Johnson MJ, Patmore RD, Howard MR, Howell DA.

BMC Palliat Care. 2018 Feb 21;17(1):33. doi: 10.1186/s12904-018-0289-1.

12.

Determinants of hospital death in haematological cancers: findings from a qualitative study.

McCaughan D, Roman E, Smith AG, Garry A, Johnson M, Patmore R, Howard M, Howell DA.

BMJ Support Palliat Care. 2018 Mar;8(1):78-86. doi: 10.1136/bmjspcare-2016-001289. Epub 2017 Jun 29.

13.

Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network.

Kane E, Howell D, Smith A, Crouch S, Burton C, Roman E, Patmore R.

Eur J Cancer. 2017 Jun;78:53-60. doi: 10.1016/j.ejca.2017.03.013. Epub 2017 Apr 13.

14.

Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study.

Howell D, Smith A, Appleton S, Bagguley T, Macleod U, Cook G, Patmore R, Roman E.

Br J Haematol. 2017 Apr;177(1):67-71. doi: 10.1111/bjh.14513. Epub 2017 Feb 1.

15.

Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.

Roman E, Smith A, Appleton S, Crouch S, Kelly R, Kinsey S, Cargo C, Patmore R.

Cancer Epidemiol. 2016 Jun;42:186-98. doi: 10.1016/j.canep.2016.03.011. Epub 2016 Apr 16.

16.

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort.

Wang HI, Smith A, Aas E, Roman E, Crouch S, Burton C, Patmore R.

Eur J Health Econ. 2017 Mar;18(2):255-267. doi: 10.1007/s10198-016-0775-4. Epub 2016 Mar 11.

17.

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma.

Smith A, Crouch S, Howell D, Burton C, Patmore R, Roman E.

Cancer Epidemiol. 2015 Dec;39(6):1103-12. doi: 10.1016/j.canep.2015.08.015. Epub 2015 Sep 2.

18.

Preferred and actual place of death in haematological malignancy.

Howell DA, Wang HI, Roman E, Smith AG, Patmore R, Johnson MJ, Garry A, Howard M.

BMJ Support Palliat Care. 2017 Jun;7(2):150-157. doi: 10.1136/bmjspcare-2014-000793. Epub 2015 Jul 8.

19.

Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.

Smith A, Crouch S, Lax S, Li J, Painter D, Howell D, Patmore R, Jack A, Roman E.

Br J Cancer. 2015 Apr 28;112(9):1575-84. doi: 10.1038/bjc.2015.94. Epub 2015 Mar 24.

20.

Costed Treatment Pathways of Diffuse Large B Cell Lymphoma in a UK Population-Based Cohort: A Patient Level Simulation Model.

Wang HI, Smith A, Roman E, Crouch S, Jack A, Patmore R.

Value Health. 2014 Nov;17(7):A624-5. doi: 10.1016/j.jval.2014.08.2221. Epub 2014 Oct 26. No abstract available.

21.

Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myeloma.

Howell DA, Wang HI, Roman E, Smith AG, Patmore R, Johnson MJ, Garry AC, Howard MR.

BMJ Support Palliat Care. 2015 Dec;5(5):496-502. doi: 10.1136/bmjspcare-2013-000578. Epub 2014 Feb 19.

22.

Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model.

Wang HI, Aas E, Howell D, Roman E, Patmore R, Jack A, Smith A.

Value Health. 2014 Mar;17(2):205-14. doi: 10.1016/j.jval.2013.12.007.

23.

Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort.

Smith AG, Painter D, Howell DA, Evans P, Smith G, Patmore R, Jack A, Roman E.

BMJ Open. 2014 Jan 15;4(1):e004266. doi: 10.1136/bmjopen-2013-004266.

24.

Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death.

Howell DA, Wang HI, Smith AG, Howard MR, Patmore RD, Roman E.

BMC Palliat Care. 2013 Nov 19;12(1):42. doi: 10.1186/1472-684X-12-42.

25.

Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network.

Howell DA, Smith AG, Jack A, Patmore R, Macleod U, Mironska E, Roman E.

BMC Hematol. 2013 Oct 31;13(1):9. doi: 10.1186/2052-1839-13-9.

26.

Return of the spleens.

Bangalorelakshminarayana U, Patmore R, Dore P, Jayan R, Greenstone M.

Br J Hosp Med (Lond). 2013 Jul;74(7):412-3. No abstract available.

PMID:
24159647
27.

Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.

Leblond V, Johnson S, Chevret S, Copplestone A, Rule S, Tournilhac O, Seymour JF, Patmore RD, Wright D, Morel P, Dilhuydy MS, Willoughby S, Dartigeas C, Malphettes M, Royer B, Ewings M, Pratt G, Lejeune J, Nguyen-Khac F, Choquet S, Owen RG.

J Clin Oncol. 2013 Jan 20;31(3):301-7. doi: 10.1200/JCO.2012.44.7920. Epub 2012 Dec 10.

PMID:
23233721
28.

Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome.

Barrans SL, Crouch S, Care MA, Worrillow L, Smith A, Patmore R, Westhead DR, Tooze R, Roman E, Jack AS.

Br J Haematol. 2012 Nov;159(4):441-53. doi: 10.1111/bjh.12045. Epub 2012 Sep 13.

PMID:
22970711
29.

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.

Smith A, Howell D, Patmore R, Jack A, Roman E.

Br J Cancer. 2011 Nov 22;105(11):1684-92. doi: 10.1038/bjc.2011.450. Epub 2011 Nov 1.

30.

Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data.

Howell DA, Shellens R, Roman E, Garry AC, Patmore R, Howard MR.

Palliat Med. 2011 Sep;25(6):630-41. doi: 10.1177/0269216310391692. Epub 2011 Jan 12. Review.

PMID:
21228094
31.

Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy.

Howell DA, Roman E, Cox H, Smith AG, Patmore R, Garry AC, Howard MR.

BMC Palliat Care. 2010 Jun 1;9:9. doi: 10.1186/1472-684X-9-9.

32.

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab.

Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R, Roman E, Jack A.

J Clin Oncol. 2010 Jul 10;28(20):3360-5. doi: 10.1200/JCO.2009.26.3947. Epub 2010 May 24.

PMID:
20498406
33.

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.

Smith A, Roman E, Howell D, Jones R, Patmore R, Jack A; Haematological Malignancy Research Network.

Br J Haematol. 2010 Mar;148(5):739-53. doi: 10.1111/j.1365-2141.2009.08010.x. Epub 2009 Dec 1.

34.

Brachial plexopathy following high-dose melphalan and autologous peripheral blood stem cell transplantation.

Parrish C, Ming A, Patmore R, Shields M, Allsup D.

Bone Marrow Transplant. 2010 May;45(5):951-2. doi: 10.1038/bmt.2009.243. Epub 2009 Sep 21. No abstract available.

PMID:
19767786
35.

Development of EBV-associated diffuse large B-cell lymphoma in Waldenstrom macroglobulinemia and mantle cell lymphoma.

Varghese AM, Sayala H, Evans PA, O'Connor SJ, Patmore R, Hillmen P, Owen RG.

Leuk Lymphoma. 2008 Aug;49(8):1618-9. doi: 10.1080/10428190802123481. No abstract available.

PMID:
18608870
36.

Inhaled nitrous oxide (Entonox) as a short acting sedative during bone marrow examination.

Steedman B, Watson J, Ali S, Shields ML, Patmore RD, Allsup DJ.

Clin Lab Haematol. 2006 Oct;28(5):321-4.

PMID:
16999723
37.

Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation.

Rawstron AC, Davies FE, DasGupta R, Ashcroft AJ, Patmore R, Drayson MT, Owen RG, Jack AS, Child JA, Morgan GJ.

Blood. 2002 Nov 1;100(9):3095-100.

38.

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma.

Barrans SL, Carter I, Owen RG, Davies FE, Patmore RD, Haynes AP, Morgan GJ, Jack AS.

Blood. 2002 Feb 15;99(4):1136-43.

39.

Effects of fenoxycarb on development and reproduction of the oriental cockroach, Blatta orientalis.

Evans RG, Sunley A, Bradford C, Patmore RI.

Med Vet Entomol. 1995 Jul;9(3):235-40.

PMID:
7548939
40.
41.

Intravenous line infections.

Kerr KG, Anson JJ, Patmore R, Smith G.

J Hosp Infect. 1994 Jan;26(1):73-5. No abstract available.

PMID:
7910187
42.

Effects of chronic administration of benfluorex to rats on the metabolism of corticosterone, glucose, triacylglycerols, glycerol and fatty acid.

Brindley DN, Akester H, Derrick GP, Irvine CD, Patmore RD, Spencer H, Yule-Smith A, Finnerty C, Saxton J, Macdonald IA, et al.

Biochem Pharmacol. 1988 Feb 15;37(4):695-705.

PMID:
3342101

Supplemental Content

Loading ...
Support Center